Fingerprint Dive into the research topics of 'Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
Agata Ptaszynska, Samuel M. Cohen, Edward M. Messing, Timothy P. Reilly, Eva Johnsson, Kristina Johnsson
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations